002044SZSE

"Meinian Onehealth Industry Holdings Co., Ltd. Issuance of Shares for Asset Acquisition and Related Party Transaction Report (Draft) (Second Revised Version)"

✨ AI Summary

This announcement outlines the proposed issuance of shares by Meinian Onehealth to acquire assets from 37 related parties, including significant stakes in various health management companies. The transaction aims to enhance the company's operational capabilities and market position. Adjustments to the transaction include a reduction in the number of counterparties and assets involved, which do not materially affect the overall deal structure.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Stock Code: 002044.SZ

Stock Abbreviation: Meinian Health

Listing Location: Shenzhen Stock Exchange

Announcement of the Issuance of Shares for Asset Acquisition and Related Party Transaction Report (Draft) (Second Revised Version)

1. Declaration

The terms or abbreviations described in this section have the same meanings as those defined in the "Definitions" section of this report.

  1. Company Declaration
    The company and all its directors, supervisors, and senior management guarantee the authenticity, accuracy, and completeness of the information provided for this transaction. There are no false records, misleading statements, or significant omissions, and they bear corresponding legal responsibilities for the provided information. If any losses are caused to investors due to false records, misleading statements, or significant omissions, the company will bear compensation liability according to law. The actual controller of the company and their concerted actors, as well as all directors, supervisors, and senior management, commit that if this transaction is investigated by judicial authorities or the China Securities Regulatory Commission (CSRC) due to suspected false records, misleading statements, or significant omissions, they will suspend the transfer of shares held in the company until the investigation concludes. If the investigation finds violations, the locked shares will be voluntarily used for compensation arrangements for relevant investors. This report does not represent any substantive judgment or guarantee regarding the investment value or returns of the company's stock by the CSRC or the Shenzhen Stock Exchange (SZSE). The company is responsible for any changes in operations and earnings after the transaction, and investors bear the investment risks arising from this transaction. Investors should carefully consider the risk factors disclosed in this report when evaluating the transaction. If investors have any questions regarding this report, they should consult their stock brokers, lawyers, professional accountants, or other professional advisors.

  2. Counterparty Declaration
    The counterparties to this transaction have provided commitments to ensure the authenticity, accuracy, and completeness of the information provided for this transaction. They bear corresponding legal responsibilities for the provided information. If any losses are caused to investors due to false records, misleading statements, or significant omissions, they will bear compensation liability according to law. If this transaction is investigated by judicial authorities or the CSRC due to suspected false records, misleading statements, or significant omissions, they will suspend the transfer of shares held in the company until the investigation concludes.

  3. Declaration by Related Securities Service Institutions and Personnel
    The securities service institutions and personnel involved in this transaction commit that the content of the application documents provided for this transaction is true, accurate, and complete, with no false records, misleading statements, or significant omissions, and they bear corresponding legal responsibilities. If the application documents contain false records, misleading statements, or significant omissions, the securities service institutions will bear corresponding legal responsibilities for failing to exercise due diligence.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.